BACKGROUND: Baseline values for daily step counts in US adults with COPD and knowledge of its accurate measurement, natural change over time, and independent relationships with measures of COPD severity are limited. METHODS: 127 persons with stable COPD wore the StepWatch Activity Monitor (SAM) for 14 days, and 102 of them wore it a median 3.9 months later. SAM counts were compared to manual counts in the clinic. We assessed change over time, the effect of season, and relationships with forced expiratory volume in 1 s (FEV(1)) % predicted, 6-min walk test (6MWT) distance, the modified Medical Research Council (MMRC) dyspnea score, and the St. George's Respiratory Questionnaire Total Score (SGRQ-TS). RESULTS: 98% of subjects were males, with mean age 71 ± 8 years and FEV(1) 1.48 ± 0.54 L (52 ± 19% predicted). All 4 GOLD stages were represented, with the most subjects in GOLD II (44%) and GOLD III (37%). The SAM had >90% accuracy in 99% of subjects. Average step count was 5680 steps/day, which decreased with increasing GOLD stage (p = 0.0046). Subjects walked 645 fewer steps/day at follow-up, which was partly explained by season of monitoring (p = 0.013). In a multivariate model, FEV(1) % predicted, 6MWT distance and MMRC score were weakly associated with daily step counts, while SGRQ-TS was not. CONCLUSIONS: These findings will aid the design of future studies using daily step counts in COPD. Accurately measured, daily step counts decline over time partly due to season and capture unique information about COPD status. Published by Elsevier Ltd.
BACKGROUND: Baseline values for daily step counts in US adults with COPD and knowledge of its accurate measurement, natural change over time, and independent relationships with measures of COPD severity are limited. METHODS: 127 persons with stable COPD wore the StepWatch Activity Monitor (SAM) for 14 days, and 102 of them wore it a median 3.9 months later. SAM counts were compared to manual counts in the clinic. We assessed change over time, the effect of season, and relationships with forced expiratory volume in 1 s (FEV(1)) % predicted, 6-min walk test (6MWT) distance, the modified Medical Research Council (MMRC) dyspnea score, and the St. George's Respiratory Questionnaire Total Score (SGRQ-TS). RESULTS: 98% of subjects were males, with mean age 71 ± 8 years and FEV(1) 1.48 ± 0.54 L (52 ± 19% predicted). All 4 GOLD stages were represented, with the most subjects in GOLD II (44%) and GOLD III (37%). The SAM had >90% accuracy in 99% of subjects. Average step count was 5680 steps/day, which decreased with increasing GOLD stage (p = 0.0046). Subjects walked 645 fewer steps/day at follow-up, which was partly explained by season of monitoring (p = 0.013). In a multivariate model, FEV(1) % predicted, 6MWT distance and MMRC score were weakly associated with daily step counts, while SGRQ-TS was not. CONCLUSIONS: These findings will aid the design of future studies using daily step counts in COPD. Accurately measured, daily step counts decline over time partly due to season and capture unique information about COPD status. Published by Elsevier Ltd.
Authors: Denis E O'Donnell; Richard Casaburi; Walter Vincken; Luis Puente-Maestu; James Swales; David Lawrence; Benjamin Kramer Journal: Respir Med Date: 2011-04-16 Impact factor: 3.415
Authors: Fabio Pitta; Thierry Troosters; Martijn A Spruit; Vanessa S Probst; Marc Decramer; Rik Gosselink Journal: Am J Respir Crit Care Med Date: 2005-01-21 Impact factor: 21.405
Authors: Judith Garcia-Aymerich; Ignasi Serra; Federico P Gómez; Eva Farrero; Eva Balcells; Diego A Rodríguez; Jordi de Batlle; Elena Gimeno; David Donaire-Gonzalez; Mauricio Orozco-Levi; Jaume Sauleda; Joaquim Gea; Robert Rodriguez-Roisin; Josep Roca; Àlvar G Agustí; Josep M Antó Journal: Chest Date: 2009-03-02 Impact factor: 9.410
Authors: Marilyn L Moy; Riley J Collins; Carlos H Martinez; Reema Kadri; Pia Roman; Robert G Holleman; Hyungjin Myra Kim; Huong Q Nguyen; Miriam D Cohen; David E Goodrich; Nicholas D Giardino; Caroline R Richardson Journal: Chest Date: 2015-07 Impact factor: 9.410
Authors: Emily S Wan; Ana Kantorowski; Diana Homsy; Merilee Teylan; Reema Kadri; Caroline R Richardson; David R Gagnon; Eric Garshick; Marilyn L Moy Journal: Respir Med Date: 2017-07-25 Impact factor: 3.415
Authors: Arjun Gupta; Tyler Stewart; Nizar Bhulani; Ying Dong; Zain Rahimi; Kimberli Crane; Chad Rethorst; Muhammad S Beg Journal: JCO Clin Cancer Inform Date: 2018-12
Authors: Emily S Wan; Ana Kantorowski; Madeline Polak; Reema Kadri; Caroline R Richardson; David R Gagnon; Eric Garshick; Marilyn L Moy Journal: Respir Med Date: 2020-01-11 Impact factor: 3.415
Authors: Marilyn L Moy; Peter M Wayne; Daniel Litrownik; Douglas Beach; Elizabeth S Klings; Roger B Davis; Gloria Y Yeh Journal: Contemp Clin Trials Date: 2015-09-08 Impact factor: 2.226
Authors: Valentin Prieto-Centurion; Nina Bracken; Lourdes Norwick; Farhan Zaidi; Amelia A Mutso; Victoria Morken; David B Coultas; Cynthia S Rand; David X Marquez; Jerry A Krishnan Journal: Chronic Obstr Pulm Dis Date: 2016
Authors: Christine M Fitzgibbons; Rebekah L Goldstein; Daniel J Gottlieb; Marilyn L Moy Journal: J Clin Sleep Med Date: 2019-07-15 Impact factor: 4.062